Life sciences
Our specialist life sciences team understand the complex nature of the sector.
Time-to-market and funding are the crucial factors driving innovation and successful new pharmaceutical product launches, which in turn, require laboratories, vivaria, pilot plants and manufacturing facilities. Avison Young’s specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risk.
We’ve successfully addressed the risks that surround real estate decision making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering and constructing any type of life science space.

News and updates
-
Avison Young bolsters London Capital Markets team with five new hires21 July 2026 -
UK Big Box take-up surpasses five-year average as occupier demand stays resilient13 July 2026 -
Avison Young names Head of Hotel Capital Markets06 July 2026 -
Avison Young supports IMA’s acquisition of The Malthouse in Leeds02 July 2026